-
1
-
-
0242662539
-
Inhibition of fibrocyte differentiation by serum amyloid P
-
Pilling D, Buckley CD, Salmon M, Gomer RH. Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol 2003;171:5537-46.
-
(2003)
J Immunol
, vol.171
, pp. 5537-5546
-
-
Pilling, D.1
Buckley, C.D.2
Salmon, M.3
Gomer, R.H.4
-
2
-
-
0034687703
-
Role of serum amyloid P component in bacterial infection: Protection of the host or protection of the pathogen
-
Noursadeghi M, Bickcrstaff MC, Gallimore JR, Herbert J, Cohen J, Pepys MB. Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. Proc Natl Acad Sci USA 2000;97:14584-9.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 14584-14589
-
-
Noursadeghi, M.1
Bickcrstaff, M.C.2
Gallimore, J.R.3
Herbert, J.4
Cohen, J.5
Pepys, M.B.6
-
3
-
-
0037118028
-
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis
-
Pepys MB, Herbert J, Hutchinson WL, Tennent GA, Lachmann HJ, Gallimore JR, et al. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature 2002;417:254-9.
-
(2002)
Nature
, vol.417
, pp. 254-259
-
-
Pepys, M.B.1
Herbert, J.2
Hutchinson, W.L.3
Tennent, G.A.4
Lachmann, H.J.5
Gallimore, J.R.6
-
4
-
-
0030757182
-
Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene
-
Botto M, Hawkins PN, Bickerstaff MC, Herbert J, Bygrave AE, McBride A, et al. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nature Med 1997;3:855-9.
-
(1997)
Nature Med
, vol.3
, pp. 855-859
-
-
Botto, M.1
Hawkins, P.N.2
Bickerstaff, M.C.3
Herbert, J.4
Bygrave, A.E.5
McBride, A.6
-
5
-
-
33845342873
-
Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice
-
Haudek SB, Xia Y, Huebener P, Lee JM, Carlson S, Crawford JR, et al. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci U S A 2006;103:18284-9.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 18284-18289
-
-
Haudek, S.B.1
Xia, Y.2
Huebener, P.3
Lee, J.M.4
Carlson, S.5
Crawford, J.R.6
-
6
-
-
0018425762
-
Serum amyloid P-component is an acute-phase reactant in the mouse
-
Pepys MB, Baltz M, Gomer K, Davies AJ, Doenhoff M. Serum amyloid P-component is an acute-phase reactant in the mouse. Nature 1979;278:259-61.
-
(1979)
Nature
, vol.278
, pp. 259-261
-
-
Pepys, M.B.1
Baltz, M.2
Gomer, K.3
Davies, A.J.4
Doenhoff, M.5
-
7
-
-
0021961144
-
Studies of the in vivo synthesis and catabolism of serum amyloid P component (SAP) in the mouse
-
Baltz ML, Dyck RF, Pepys MB. Studies of the in vivo synthesis and catabolism of serum amyloid P component (SAP) in the mouse. Clin Exp Immunol 1985;59:235-42.
-
(1985)
Clin Exp Immunol
, vol.59
, pp. 235-242
-
-
Baltz, M.L.1
Dyck, R.F.2
Pepys, M.B.3
-
8
-
-
0000186474
-
Amyloid P component: A critical review
-
Pepys MB, Booth DR, Hutchinson WL, Gallimore JR, Collins PM, Hohenester E. Amyloid P component: a critical review. Amyloid: Int J Exp Clin Invest 1997;4:274-95.
-
(1997)
Amyloid: Int J Exp Clin Invest
, vol.4
, pp. 274-295
-
-
Pepys, M.B.1
Booth, D.R.2
Hutchinson, W.L.3
Gallimore, J.R.4
Collins, P.M.5
Hohenester, E.6
|